Wehbe et al
For clinicians and patients, the practical timeline matters: CagriSema is closer to potential approval (phase 3 complete), while amycretin's phase 3 is planned for 2026
SAAR diverts glucose toward asparagine synthesis Given that loss of hepatic PSAT1 blunted, but did not completely abolish the improvement in glucose tolerance by SAAR, we further examined how SAAR could be influencing glucose metabolism in the liver
Modele behawioralne gryzoni poczone z analiz osi odkowo-jelitowej, badania szlaku NO oraz dwukierunkowej komunikacji jelito-mzg (Sikiric i wsp
TB-500 (10mg): A synthetic fraction of Thymosin Beta-4 studied for cellular migration
Summary Keywords tamoxifen, breast cancer, cell cycle regulators, autophagy, resistance Citation Yao J, Deng K, Huang J, Zeng R and Zuo J (2020) Progress in the Understanding of the Mechanism of Tamoxifen Resistance in Breast Cancer